studygraphics

#VisualAbstract: BMI and serum lipid levels reductions were greater after doudenal switch surgery vs. Roux-en-Y-gastric bypass over 10 years

Jun 15, 2024

Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...

Read More

#VisualAbstract: Belantamab Mafodotin, Pomalidomide, and Dexamethasone Improve Outcomes in Multiple Myeloma

Jun 14, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Crinecerfont Improves Outcomes in Pediatric Congenital Adrenal Hyperplasia Patients

Jun 12, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Oral azacitidine did not improve progres-sion-free survival but had a better safety profile for follicular helper T-cell lymphoma

Jun 8, 2024

Click here to read this study in The Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 7, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Dupilumab Improves Outcomes in COPD with Blood Eosinophil Evidence of Type 2 Inflammation

Jun 5, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Ticagrelor monotherapy reduces bleeding risk following percutaneous coronary intervention

Jun 4, 2024

1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the...

Read More

#VisualAbstract: Nirmatrelvir does not decrease symptom duration of COVID-19

May 31, 2024

1. In this randomized controlled trial, there was no difference in the median time to sustained alleviation of coronavirus disease 2019 (COVID-19) symptoms between participants who received nirmatrelvir versus placebo. 2. The...

Read More

#VisualAbstract: Intensive Ambulance-Delivered Blood-Pressure Reduction Does Not Improve Outcomes in Hyperacute Stroke

May 29, 2024

Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...

Read More

#VisualAbstract: Single-Agent Trabectedin was noninferior to physicianAND#8217;s choice control chemotherapy in recurrent ovarian cancer

May 25, 2024

Click here to read this study in the Journal of Clinical Oncology ©2024 2 Minute Medicine, Inc....

Read More

#VisualAbstract: Ponatinib is Superior to Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

May 23, 2024

Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

May 22, 2024

Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...

Read More

#VisualAbstract: Intra-Articular Platelet-Rich Plasma Injection After Anterior Cruciate Ligament Reconstruction has No Impact on Recovery

May 21, 2024

Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Dequalinium chloride, a broad spectrum antiseptic, is non-inferior to metronidazole for bacterial vaginosis

May 18, 2024

Click here to read the study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...

Read More

#VisualAbstract: The Use of Aspirin as an Adjuvant Therapy has No Impact on Breast Cancer

May 17, 2024

Click here to read the study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...

Read More

#VisualAbstract: Semaglutide Improves Outcomes in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

May 15, 2024

Click here to to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with locally advanced cervical cancer

May 14, 2024

1. Progression-free survival at 24 months was higher in the pembrolizumab versus...

Read More

#VisualAbstract: Recombinant ADAMTS13 Prophylaxis Leads to Rare Thrombotic Thrombocytopenic Purpura Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura

May 9, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...

Read More

#VisualAbstract: Apolipoprotein A1 Infusions do not Improve Cardiovascular Outcomes after Acute Myocardial Infarction

May 8, 2024

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...

Read More

#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

May 7, 2024

Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...

Read More

1
…
4
5
6
…
26